FIELD: medicine, pharmaceutics.
SUBSTANCE: invention describes a system of carrier microparticles containing one or more proteins, peptides, nucleic acids, carbohydrates, lipids or other biologically active substances with or without attached target molecules. The invention describes immunomodulatory compounds for induction of an immunomodulatory effect - protective immunity and tolerance. The immunobiologically active compound contains a pathogen-associated molecular structure and a carrier in the form of agarose microparticles. The molecular structure represents at least an immunobiologically active antigen and an antigen epitope with the antigen epitope is a peptide, a protein, a recombinant peptide or a multipeptide, a lipid, a carbohydrate, a nucleic acid or their combinations. There are described methods for identifying the immunobiologically active peptides for preparing the immunobiologically active compounds and methods for inducing a tolerant immune response and enhancing immunity with the use of the compounds described in the invention.
EFFECT: invention provides stable compounds with the wide range of immunogens and target molecules enables stimulating protective immunity and tolerance in both infected, and non-infected hosts.
52 cl, 5 dwg, 4 tbl, 34 ex
Title | Year | Author | Number |
---|---|---|---|
IMMUNOSTIMULATING COMBINATION FOR PREVENTION AND TREATMENT OF HEPATITIS C | 2006 |
|
RU2431499C2 |
IMPROVED IMMUNOLOGICAL COMPOSITION | 2012 |
|
RU2664730C2 |
DETERMINATION OF DOSE FOR IMMUNOTHERAPEUTIC AGENTS | 2017 |
|
RU2771717C2 |
METHOD OF PRODUCING RECOMBINANT VACCINE | 2010 |
|
RU2444570C1 |
USE OF MONOMYCOLYL GLYCEROL (MMG) AS ADJUVANT | 2008 |
|
RU2479317C2 |
METHODS OF PRODUCING ADJUVANTED VIROSOME AND ADJUVANTED VIROSOMES, OBTAINED BY SAID METHODS | 2014 |
|
RU2694367C2 |
IMMUNOSTIMULATING COMPOSITIONS | 2016 |
|
RU2732118C2 |
FUNCTIONALLY RECONSTRUCTED ADJUVANT-CONTAINING VIRUS MEMBRANES | 2004 |
|
RU2348428C2 |
IMMUNOGENIC COMPOSITIONS OF MULTIPLE ANTIGEN PRESENTATION, METHODS AND APPLICATIONS RELATING THERETO | 2012 |
|
RU2619176C2 |
T CELL SPECTRUM BROADENING FOR SUB-DOMINANT EPITOPE INCLUSION BY VACCINATION WITH ANTIGENS DELIVERED AS PROTEIN FRAGMENTS OR PEPTIDE COCKTAILS | 2007 |
|
RU2490024C2 |
Authors
Dates
2012-09-20—Published
2006-01-30—Filed